Table III.
Leukotriene pathway haplotypes.
Haplotype | Global p-value† | SNPs | Haplotype Frequency | P-value† | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Overall | Cases | Controls | |||||||||||||
ALOX5AP Three-way haplotype* | 0.003 | 1 | 2 | 3 | |||||||||||
| |||||||||||||||
G | A | T | 0.06 | 0.02 | 0.11 | 0.0009 | |||||||||
G | G | A | 0.30 | 0.31 | 0.29 | 0.81 | |||||||||
G | G | T | 0.45 | 0.43 | 0.46 | 0.85 | |||||||||
A | G | A | 0.19 | 0.24 | 0.14 | 0.01 | |||||||||
| |||||||||||||||
ALOX5AP** | 0.02 | 1 | 2 | 3 | 4 | ||||||||||
| |||||||||||||||
HapA | A | T | G | A | 0.066 | 0.109 | 0.022 | 0.0009 | |||||||
G | T | G | C | 0.316 | 0.149 | 0.109 | 0.48 | ||||||||
G | A | G | C | 0.129 | 0.351 | 0.280 | 0.59 | ||||||||
G | A | A | C | 0.049 | 0.099 | 0.142 | 0.47 | ||||||||
G | T | G | A | 0.121 | 0.033 | 0.067 | 0.28 | ||||||||
G | A | G | A | 0.319 | 0.260 | 0.380 | 0.07 | ||||||||
| |||||||||||||||
ALOX5AP** | 0.24 | 1 | 2 | 3 | 4 | ||||||||||
| |||||||||||||||
HapB | G | T | A | C | 0.496 | 0.560 | 0.430 | 0.10 | |||||||
G | A | G | C | 0.105 | 0.187 | 0.214 | 0.86 | ||||||||
A | A | A | T | 0.079 | 0.109 | 0.100 | 0.89 | ||||||||
G | A | A | C | 0.201 | NA | 0.014 | 0.64 | ||||||||
G | T | A | T | 0.006 | 0.076 | 0.079 | 0.42 | ||||||||
A | A | G | C | 0.008 | 0.000 | 0.016 | 0.23 | ||||||||
A | A | A | C | 0.105 | 0.068 | 0.146 | 0.03 | ||||||||
| |||||||||||||||
LTA4H** | 0.44 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ||||
| |||||||||||||||
HapK | C | G | T | G | A | T | T | C | G | G | 0.027 | 0.070 | NA | 0.15 | |
T | G | T | G | G | C | G | T | A | G | 0.025 | 0.039 | NA | 0.22 | ||
C | G | T | A | A | T | T | T | A | A | 0.014 | 0.017 | 0.011 | 0.25 | ||
C | G | T | G | A | C | G | C | G | G | 0.008 | NA | NA | 0.28 | ||
C | G | C | G | A | T | T | T | A | G | 0.006 | 0.012 | NA | 0.34 | ||
C | G | C | G | A | T | G | C | G | A | 0.006 | 0.011 | NA | 0.38 | ||
C | G | T | G | A | C | T | T | A | G | 0.012 | 0.019 | NA | 0.44 | ||
C | G | T | G | A | C | T | T | G | G | 0.020 | 0.023 | 0.024 | 0.58 | ||
T | G | T | G | G | C | G | C | G | G | 0.058 | 0.076 | 0.064 | 0.59 | ||
T | A | T | G | A | C | G | T | A | A | 0.104 | 0.108 | 0.100 | 0.74 | ||
T | G | T | G | G | C | G | T | A | A | 0.050 | 0.054 | 0.046 | 0.76 | ||
C | G | T | A | A | T | T | T | A | G | 0.032 | 0.035 | 0.000 | 0.82 | ||
C | G | T | G | A | T | T | T | G | G | 0.324 | 0.324 | 0.312 | 0.93 | ||
C | G | T | G | A | C | T | C | G | G | 0.012 | NA | 0.022 | 0.91 | ||
C | G | C | G | A | T | G | T | A | G | 0.006 | NA | 0.013 | 0.71 | ||
C | G | T | G | A | T | T | T | A | G | 0.062 | 0.054 | 0.080 | 0.60 | ||
C | G | T | A | A | T | T | C | G | G | 0.006 | NA | 0.011 | 0.57 | ||
C | G | T | A | A | T | T | C | A | G | 0.028 | 0.000 | 0.028 | 0.55 | ||
C | G | C | G | A | C | T | T | G | G | 0.006 | NA | 0.011 | 0.44 | ||
C | A | T | G | A | C | G | T | A | A | 0.158 | 0.142 | 0.188 | 0.36 | ||
T | G | T | G | A | T | T | T | A | G | 0.006 | NA | 0.011 | 0.31 | ||
C | G | C | G | A | T | G | T | A | A | 0.025 | NA | 0.046 | 0.01 |
Three-way haplotype composed of the individually associated ALOX5AP SNPs (rs17216473, rs17222814, rs10507391).
Adjusted for hypertension, dyslipidemia, diabetes, smoking, BMI and CADindex.
ALOX5AP (HapA): rs17222814 (1), rs10507391 (2), rs476874 (3), rs9551963 (4)
ALOX5AP (HapB): rs17216473 (1), rs10507391 (2), rs9315050 (3), rs17222842 (4)
LTA4H (HapK): 12p0557 (1), rs2660880 (2), rs6538697 (3), rs1978331 (4), rs17677715 (5), rs2247570 (6), rs2660898 (7), rs2540482 (8), rs2660845 (9), rs2540475 (10)
NA: numbers too small to converge on estimate